-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Initiates Coverage On Disc Medicine with Buy Rating, Announces Price Target of $132

Benzinga·11/09/2026 15:36:48
Listen to the news
Guggenheim analyst Debjit Chattopadhyay initiates coverage on Disc Medicine (NASDAQ:IRON) with a Buy rating and announces Price Target of $132.